Cleveland Biolabs (CBLI) Fonstein to Step Down as CEO, Will Remain Pres; Kogan Named Interim CEO
Tweet
Share
E-mailGet Alerts CBLI Hot Sheet
Join SI Premium – FREE
Cleveland Biolabs (Nasdaq: CBLI) says Michael Fonstein will step down as the company's CEO, however will remain as President. The company has named COO Yakov Kogan as the interim CEO.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NeoVolta (NEOV) Appoints Ardes Johnson as New CEO
- Ciena (CIEN) Announces Retirement of Principal Accounting Officer Andrew C. Petrik
- Hyzon Motors (HYZN) Announces Resignation of President, North America Pat Griffin
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
